Mission

The mission of Impact Melanoma is to accelerate melanoma research and clinical discovery while providing support and education to individuals and families affected by melanoma so they can navigate care with confidence and hope.

About the Organization

Impact Melanoma is a nonprofit organization committed to improving care and outcomes for people facing melanoma. They fund and promote innovative scientific research, increase awareness about prevention and early detection, and connect patients and caregivers with educational resources and supportive programs. Through collaboration with researchers, clinicians, and patient communities, Impact Melanoma helps families stay informed and empowered from diagnosis through survivorship.

Cause Areas

Melanoma Research Skin Cancer Awareness Patient Resources Family Support Education & Advocacy

Honor Their Life Through Giving

A charitable donation can be a way to honor a life. Some families choose to include a charity like IMPACT Melanoma as part of a Memoria Page or life story, especially when cancer was part of their experience. It can be a way to acknowledge that journey and offer support to others, in their memory. Including a cause is optional. It’s simply one of many ways to remember.

Memoria Sky is an informational memorial platform and does not process or manage charitable donations. Donation links direct users to external third-party websites not operated or controlled by Memoria Sky. Users should independently verify organizations before making donations. Listing an organization does not imply affiliation, sponsorship, or endorsement by Memoria Sky.

Related Charities

We respect your privacy
We use cookies to operate this website, improve usability and personalize your experience. Your privacy is important to us, and we will never sell your data. Privacy Policy.

We respect your privacy
We use cookies to operate this website, improve usability and personalize your experience. Your privacy is important to us, and we will never sell your data. Privacy Policy.